Skip to content

Science & Quality

From formulation to certification, here you will find the research work behind every product.

Where our formulations are born

“Every product is formulated entirely by our researchers, and tested in collaboration with the academic world.”

Patents

  1. Almetax®

    Industrial invention patent

    • ITA No. 0001425921
    • EU No. EP3182966
    • US No. 11090287

    Valid in

    • Belgium
    • France
    • Germany
    • United Kingdom
    • Spain
    • Switzerland/Li
    • Poland
    • Turkey
    • Italy
    • USA
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the composition in the prevention and treatment of metabolic changes related to the climacteric and menopause. Patents validated in: Belgium, France, Germany, United Kingdom, Spain, Switzerland/Li, Poland, Turkey, Italy and USA.

  2. Ivuxur®

    Industrial invention patent

    • US No. 10,300,099 B2
    • EU No. EP3182982

    Valid in

    • Germany
    • France
    • Italy
    • USA
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the composition for the treatment and prevention of urinary tract infections. Patents validated in Germany, France, Italy and USA.

  3. Miledix®

    Formulation patent

    • ITA No. 10 2018 000020932
    • EU No. EP3897597

    Valid in

    • Italy
    • Europe (EP)
    Grounds for grant

    Granted in recognition of the innovation, uniqueness and synergy of the components in the treatment of menstrual cycle disorders.

  4. Xinprox®

    Formulation patent

    • ITA No. 102020000027423

    Valid in

    • Italy
    Grounds for grant

    Granted in recognition of the innovation, uniqueness and synergy of the components in the treatment of prostate conditions.

  5. Dolatrox®

    Industrial invention patent

    • US No. 10,548,937 B2

    Valid in

    • USA
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the composition in the treatment of arthropathies and osteoarthritis.

  6. Xinepa®

    Formulation patents

    • ITA No. 0001425919
    • US No. 9,980,940
    • ISR No. 250594
    • EU No. EP3182965

    Valid in

    • Belgium
    • France
    • Germany
    • United Kingdom
    • Spain
    • Switzerland/Li
    • Poland
    • Turkey
    • Israel
    • Italy
    • USA

    Technology patents

    • ITA No. 102015000010454
    • US No. 10,413,526
    • EU No. EP3277273

    Valid in

    • Austria
    • Denmark
    • Germany
    • United Kingdom
    • Poland
    • Portugal
    • Sweden
    • Italy
    • USA
    Grounds for grant

    The formulation patents were granted for demonstrating, in a statistically significant way, the synergy of efficacy between the substances in XINEPA, for a composition for use in the treatment of neuropathies and/or neuropathic pain.

    Patents validated in: Belgium, France, Germany, United Kingdom, Spain, Switzerland/Li, Poland, Turkey, Israel, Italy, USA. The technology patents were granted for demonstrating innovation in the technology underlying the formulation. Patents validated in: Austria, Denmark, Germany, United Kingdom, Poland, Portugal, Sweden, Italy, USA.

  7. Milesax®

    Industrial invention patent

    • ITA No. 0001425920
    • US No. 10583120
    • EU No. EP3182969

    Valid in

    • Germany
    • France
    • Italy
    • USA
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the composition, which has muscle-relaxant and anti-inflammatory activity. Patents validated in Germany, France, Italy and USA.

  8. Doltendix®

    Industrial invention patent

    • ITA No. 102019000024907
    • CHN No. 202080093020.1

    Valid in

    • Italy
    • China
    Grounds for grant

    Granted in recognition of the innovation, uniqueness and synergy of the composition in the treatment of tendinopathies.

  9. Kymax®

    Industrial invention patent

    • ITA No. 102022000000842

    Valid in

    • Italy
    Grounds for grant

    Granted in recognition of the innovation, uniqueness and synergy of the composition in the prevention and treatment of Parkinson’s disease.

  10. Declinex®

    Industrial invention patent

    • ITA No. IT102022000021789

    Valid in

    • Italy
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the formulation and the synergy of the components in the prevention and management of cognitive decline and/or forms of dementia.

  11. KIP® Immuno

    Industrial invention patent

    • ITA No. IT102020000019789

    Valid in

    • Italy
    Grounds for grant

    Granted in recognition of the innovation and uniqueness of the formulation and the synergy of the components in the prevention and treatment of flu symptoms and in strengthening the immune defences.

Trademarks

Over 120trademarks and pay-offs already registered

Registered in

  • Italy
  • European Union
  • Switzerland
  • United Kingdom
  • Israel
  • USA
  • China
  • Morocco
  • Turkey
  • Russia
  • Uruguay
  • Japan
  • Libya

Further reading

If you want to go deeper: how we do research, how we choose raw materials, what our patents protect and how we protect those who choose us.

Research and developmentResearch: the heart and helm of our growth

The driving force of our work is right here, in the Research & Development department.

This is one of our distinctive features: product study and formulation are activities that we carry out and strengthen in-house.

Research is a living, pulsing asset for our company, an endless drive towards new and effective solutions, know-how that creates the future, every day.

“We have created a true research hub”

We have selected highly qualified researchers who choose the raw materials, develop the formulations and carry out in vitro tests, in close collaboration with the academic world.

Choosing raw materialsThe source of our quality

The selection of a plant extract for the development of one of our food supplements begins with careful research in scientific databases and libraries, as well as in national and international guidelines.

This is how we establish the biological and functional activity of the extract and the substances responsible for it. The next step is to identify the most qualified supplier for the chosen extract.

“Meeting our quality standard and our ethical principles is an essential requirement.”

The selection is then guided by further criteria: a higher concentration of the reference active components, the product’s technological level, its bioavailability, its organoleptic properties and the existence of supporting scientific studies. In this way we make sure of the absolute quality and effective action of the raw materials and, in turn, of each of our products.

NutraceuticalsResearch, nutrition, pharmaceutics.

Nature can release defences of great power.

By studying these mechanisms and the active components that drive them, we want to offer the medical world and people tools that support allopathic treatments, for the health of all and of each person, in their own unique characteristics.

“Our field is nutraceuticals, the fertile meeting point of nutrition and pharmaceutics”

We select substances and formulate products with a high functional content, able to interact synergistically with the body’s physiological functions, to stimulate the human body’s biological response and protect the well-being of women, men and children.

The nutraceutical moduleAn extra safeguard for consumers’ well-being

We do not hesitate to go beyond regulatory requirements to guarantee the utmost transparency and safety. That is why, in line with what the law requires of medicine manufacturers, we have chosen to adopt a Nutraceutical Vigilance system.

“An effective tool for checking products and protecting people.”

The nutraceutical module is an internal protocol that ensures the recording and analysis of reports of any side effect of our products, in the name of safety, transparency and constant improvement.

PatentsOur products are unique.

A patent is a powerful tool for businesses: it allows them to protect their investment in research and innovation and to gain additional financial resources by managing the rights to exploit it.

Today, 90% of the value of many companies lies in so-called intangible assets, which consist mostly of industrial property rights. With patent protection, a company is in a position to prevent another company from making, marketing and selling a product or composition that infringes its patent protection.

A patent portfolio demonstrates a company’s high level of quality, specialisation and technological capability. In practice, a patent brings a company real added value, as well as strengthening its position on the market.

To date Kolinpharma has obtained 10 industrial patents in Italy, 6 patents in European countries other than Italy, including Switzerland and the United Kingdom, 6 patents in the United States, 1 in Israel and 1 in China, an achievement we are very proud of in countries regarded worldwide as benchmarks in scientific research and of great importance in the world of nutraceuticals. It reflects the seriousness and accuracy of our research and confirms the ability of the R&D team to study innovative formulations and develop effective products, based on the most up-to-date scientific evidence in each field.

TrademarksCommunicating the company’s high value

For a company, registering its trademarks is a fundamental step in protecting its identity and its products on the market. A registered trademark gives a distinctive image, guaranteeing exclusive use of the name, logo or slogan.

This prevents others from exploiting the reputation and prestige the company has built through its trademark portfolio. As well as making a product recognisable, registering a trademark can help the company expand into new national and international markets.

For us at KOLINPHARMA®, a trademark is a sign that strongly distinguishes and identifies its product, a tool to reflect and protect the richness, validity, quality and potential of each formulation. A way of communicating the high value of the Company itself.

“Trademarks, like patents, mark out the unique and innovative character of KOLINPHARMA®”

Creating a trademark at KOLINPHARMA® is a brainstorming process made up of emotions, anecdotes and lived experience. The process that leads to registration is the result of know-how that over time has become a company asset, and it is supported by industry experts.

Each of these factors contributes synergistically, as in our formulations, to creating the Brand. A further distinctive feature can be found in products made of several active substances: since the synergy of their components has been demonstrated, the “X” in the name is there to highlight exactly this characteristic.

Our major investment in trademarks also shows in the numbers: to date there are over 120 trademarks and pay-offs already registered, not only in Italy but also in the European Union, Switzerland, the United Kingdom, Israel, the USA, China, Morocco, Turkey, Russia, Uruguay, Japan and Libya.

Food intolerancesHealth means respect for each person’s individuality

We want our products to be accessible also to people with intolerances to specific foods or with conditions that prevent them from eating those foods.

“Well-being is everyone’s right.”

That is why all our products are Gluten Free and can therefore also be taken by people with coeliac disease.

Our products are also free from lactose and milk, as shown by the analyses carried out on every production batch, so they are suitable for people with an intolerance too.

Corporate complianceEthics and quality are our roots.

We settle for nothing less than excellence.

That is why we go beyond what the law requires: although our products are not medicines, we have chosen to follow many of the rules that apply to the pharmaceutical world, including those on storage and distribution, which are always kept within a temperature range of 8°-25° C.

All our Medical Science Representatives hold degrees in scientific disciplines. In the same spirit, as a company we have chosen to apply and comply with Italian Legislative Decree 231/2001.

“Every person is unique. Their needs are unique. And they all deserve an answer”

Age, cultural and social background, disadvantaged situations, allergies and intolerances… our aim is to meet each person’s demand for well-being in the best possible way and beyond every expectation. Every stage of our work, from formulation to packaging, to information, all the way to communication, is shaped in constant dialogue with this principle.

Consumer protectionWell-being, care, protection and an answer to every question.

For us, at the centre there is always the person.

From company policy to the work of each Medical Science Representative, everything we do is guided by care for the consumer. All our communication, from printed materials to our relationship with doctors, is aimed at protecting them, so that the end customer can always find an answer and support.

“We do not hesitate to go beyond regulatory requirements, to guarantee the utmost transparency”

In line with what the law requires of medicine manufacturers, we have chosen to adopt a nutraceutical vigilance system: an internal protocol that ensures the recording and analysis of reports of any side effect of our products, in the name of safety, transparency and constant improvement.